Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.3B | 2.6B | 2.5B | 2.4B |
Cost of revenue | 701M | 727M | 696M | 719M |
Gross profit | 1.6B | 1.8B | 1.8B | 1.7B |
Operating expense | ||||
Research & development | 143M | 145M | 161M | 156M |
Selling general and admin | 867M | 820M | 850M | 832M |
Other operating expenses | — | — | — | — |
Operating income | 292M | 608M | 529M | 426M |
Non operating interest income | ||||
Income | 11M | 9M | 7M | 8M |
Expense | 330M | 337M | 346M | 350M |
Other income expense | -20M | -71M | -211M | -36M |
Pretax income | -47M | 209M | -21M | 48M |
Tax provision | 39M | 111M | 71M | 49M |
Net income | -86M | 98M | -92M | -1M |
Basic EPS | -0.2 | 0.3 | -0.2 | 0.0 |
Diluted EPS | -0.2 | 0.3 | -0.2 | 0.0 |
Basic average shares | 407.3M | 418.0M | 415.2M | 413.4M |
Diluted average shares | 407.3M | 418.0M | 415.2M | 415.9M |
EBITDA | 608M | 924M | 858M | 749M |
Net income from continuing op. | -86M | 98M | -92M | -1M |
Minority interests | 28M | -5M | 7M | 11M |
Preferred stock dividends | — | — | — | — |